Trimethylamine N-Oxide: A Link among Diet, Gut Microbiota, Gene Regulation of Liver and Intestine Cholesterol Homeostasis and HDL Function
暂无分享,去创建一个
M. Farràs | F. Blanco-Vaca | Marina Canyelles | J. Escolà-Gil | L. Cedó | M. Tondo | Marina Canyelles | Mireia Tondo | Lídia Cedó | Marta Farràs | Joan Carles Escolà-Gil | Francisco Blanco-Vaca | M. Canyelles
[1] G. Morahan,et al. Type 1 diabetes: lessons for other autoimmune diseases? , 2008, Journal of autoimmunity.
[2] P. Kovanen,et al. The role of the gut in reverse cholesterol transport--focus on the enterocyte. , 2013, Progress in lipid research.
[3] M. Makishima,et al. Identification of a nuclear receptor for bile acids. , 1999, Science.
[4] P. Stenvinkel,et al. Serum Trimethylamine-N-Oxide Is Strongly Related to Renal Function and Predicts Outcome in Chronic Kidney Disease , 2016, PloS one.
[5] P. Hylemon,et al. Bile acids and the gut microbiome , 2014, Current opinion in gastroenterology.
[6] F. Bushman,et al. Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis , 2013, Nature Medicine.
[7] D. Absher,et al. Genome- and CD4+ T-cell methylome-wide association study of circulating trimethylamine-N-oxide in the Genetics of Lipid Lowering Drugs and Diet Network (GOLDN). , 2017, Journal of nutrition & intermediary metabolism.
[8] P. Turnbaugh,et al. Microbial ecology: Human gut microbes associated with obesity , 2006, Nature.
[9] A. von Eckardstein,et al. Intra-individual variation of plasma trimethylamine-N-oxide (TMAO), betaine and choline over 1 year , 2017, Clinical chemistry and laboratory medicine.
[10] R. Obeid,et al. Plasma trimethylamine N-oxide concentration is associated with choline, phospholipids, and methyl metabolism. , 2016, The American journal of clinical nutrition.
[11] F. Chen,et al. Effects of Anacetrapib in Patients With Atherosclerotic Vascular Disease , 2018 .
[12] J. M. Brown,et al. Biliary and nonbiliary contributions to reverse cholesterol transport , 2012, Current opinion in lipidology.
[13] T. Meyer,et al. Mechanism of Prominent Trimethylamine Oxide (TMAO) Accumulation in Hemodialysis Patients , 2015, PloS one.
[14] L. Räber,et al. Gut microbiota-dependent trimethylamine N-oxide in acute coronary syndromes: a prognostic marker for incident cardiovascular events beyond traditional risk factors , 2017, European heart journal.
[15] Donald J L Jones,et al. Trimethylamine N-oxide and Risk Stratification after Acute Myocardial Infarction. , 2017, Clinical chemistry.
[16] S. Hazen,et al. Prognostic value of choline and betaine depends on intestinal microbiota-generated metabolite trimethylamine-N-oxide. , 2014, European heart journal.
[17] Jeffrey I. Gordon,et al. Mechanisms underlying the resistance to diet-induced obesity in germ-free mice , 2007, Proceedings of the National Academy of Sciences.
[18] Fredrik H. Karlsson,et al. Gut metagenome in European women with normal, impaired and diabetic glucose control , 2013, Nature.
[19] Yan He,et al. Dysbiosis of Gut Microbiota With Reduced Trimethylamine‐N‐Oxide Level in Patients With Large‐Artery Atherosclerotic Stroke or Transient Ischemic Attack , 2015, Journal of the American Heart Association.
[20] Ji Miao,et al. Flavin-containing monooxygenase 3 as a potential player in diabetes-associated atherosclerosis , 2015, Nature Communications.
[21] A. von Eckardstein,et al. Plasma Concentrations of Trimethylamine-N-oxide Are Directly Associated with Dairy Food Consumption and Low-Grade Inflammation in a German Adult Population. , 2016, The Journal of nutrition.
[22] S. Hazen,et al. The gut microbiome as novel cardio-metabolic target: the time has come! , 2014, European heart journal.
[23] Ming-Huei Chen,et al. A genome-wide association study of the human metabolome in a community-based cohort. , 2013, Cell metabolism.
[24] K. Rajakumar,et al. Carnitine metabolism to trimethylamine by an unusual Rieske-type oxygenase from human microbiota , 2014, Proceedings of the National Academy of Sciences.
[25] A. Darzi,et al. Gut microbiome-host interactions in health and disease , 2011, Genome Medicine.
[26] F. Rey,et al. Intestinal Microbiota Composition Modulates Choline Bioavailability from Diet and Accumulation of the Proatherogenic Metabolite Trimethylamine-N-Oxide , 2015, mBio.
[27] P. Ferrario,et al. Associations of current diet with plasma and urine TMAO in the KarMeN study: direct and indirect contributions. , 2017, Molecular nutrition & food research.
[28] D. Rader,et al. Macrophage reverse cholesterol transport: key to the regression of atherosclerosis? , 2006, Circulation.
[29] D. Pieper,et al. Uncovering the trimethylamine-producing bacteria of the human gut microbiota , 2017, Microbiome.
[30] A. Gotto,et al. HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events. , 2007, The New England journal of medicine.
[31] J. Danesh,et al. Large-scale association analysis identifies new risk loci for coronary artery disease , 2013 .
[32] E. Balskus,et al. Microbial conversion of choline to trimethylamine requires a glycyl radical enzyme , 2012, Proceedings of the National Academy of Sciences.
[33] S. Hazen,et al. Prognostic value of elevated levels of intestinal microbe-generated metabolite trimethylamine-N-oxide in patients with heart failure: refining the gut hypothesis. , 2014, Journal of the American College of Cardiology.
[34] J. DiNicolantonio,et al. L-carnitine in the secondary prevention of cardiovascular disease: systematic review and meta-analysis. , 2013, Mayo Clinic proceedings.
[35] D. Rader. Molecular regulation of HDL metabolism and function: implications for novel therapies. , 2006, The Journal of clinical investigation.
[36] D. Rader,et al. Trials and Tribulations of CETP Inhibitors. , 2018, Circulation research.
[37] H. Verkade,et al. Reverse Cholesterol Transport Is Increased in Germ-Free Mice—Brief Report , 2017, Arteriosclerosis, thrombosis, and vascular biology.
[38] D. Gevers,et al. The Gut Microbiome Contributes to a Substantial Proportion of the Variation in Blood Lipids , 2015, Circulation research.
[39] M. Landray,et al. Effects of Anacetrapib in Patients with Atherosclerotic Vascular Disease , 2017, The New England journal of medicine.
[40] T. Esposito,et al. Regulation of flavin-containing mono-oxygenase (Fmo3) gene expression by steroids in mice and humans , 2014, Hormone molecular biology and clinical investigation.
[41] Brian J. Bennett,et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease , 2011, Nature.
[42] S. Hazen,et al. Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. , 2013, The New England journal of medicine.
[43] G. Musso,et al. Interactions between gut microbiota and host metabolism predisposing to obesity and diabetes. , 2011, Annual review of medicine.
[44] Brian J. Bennett,et al. Flavin containing monooxygenase 3 exerts broad effects on glucose and lipid metabolism and atherosclerosis[S] , 2015, Journal of Lipid Research.
[45] Richard G. Lee,et al. The TMAO-Producing Enzyme Flavin-Containing Monooxygenase 3 Regulates Obesity and the Beiging of White Adipose Tissue. , 2017, Cell reports.
[46] F. Bäckhed,et al. Impact of Gut Microbiota and Diet on the Development of Atherosclerosis in Apoe−/− Mice , 2018, Arteriosclerosis, thrombosis, and vascular biology.
[47] S. Kliewer,et al. Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis. , 2005, Cell metabolism.
[48] A. Sulpizio,et al. L‐carnitine intake and high trimethylamine N‐oxide plasma levels correlate with low aortic lesions in ApoE−/− transgenic mice expressing hCETP , 2016, Atherosclerosis.
[49] P. Kovanen,et al. HDL functionality in reverse cholesterol transport--Challenges in translating data emerging from mouse models to human disease. , 2016, Biochimica et biophysica acta.
[50] A. Dyer,et al. Accumulated Evidence on Fish Consumption and Coronary Heart Disease Mortality: A Meta-Analysis of Cohort Studies , 2004, Circulation.
[51] T. V. van Dijk,et al. Activation of the Liver X Receptor Stimulates Trans-intestinal Excretion of Plasma Cholesterol* , 2009, The Journal of Biological Chemistry.
[52] R. Schugar,et al. Emerging roles of flavin monooxygenase 3 in cholesterol metabolism and atherosclerosis , 2015, Current opinion in lipidology.
[53] M. Krempf,et al. Perinatal Hypercholesterolemia Exacerbates Atherosclerosis Lesions in Offspring by Altering Metabolism of Trimethylamine-N-Oxide and Bile Acids , 2017, Arteriosclerosis, thrombosis, and vascular biology.
[54] P. Bork,et al. A human gut microbial gene catalogue established by metagenomic sequencing , 2010, Nature.
[55] O. Djurdjev,et al. Advanced chronic kidney disease populations have elevated trimethylamine N-oxide levels associated with increased cardiovascular events. , 2016, Kidney international.
[56] V. Tremaroli,et al. Functional interactions between the gut microbiota and host metabolism , 2012, Nature.
[57] J. Spertus,et al. Serum Trimethylamine-N-Oxide is Elevated in CKD and Correlates with Coronary Atherosclerosis Burden. , 2016, Journal of the American Society of Nephrology : JASN.
[58] M. Dadlez,et al. Trimethylamine-N-oxide: a carnitine-derived metabolite that prolongs the hypertensive effect of angiotensin II in rats. , 2014, The Canadian journal of cardiology.
[59] P. Yancey,et al. Organic osmolytes as compatible, metabolic and counteracting cytoprotectants in high osmolarity and other stresses , 2005, Journal of Experimental Biology.
[60] Birsen Can Demirdöğen,et al. Flavin containing monooxygenase 3 genetic polymorphisms Glu158Lys and Glu308Gly and their relation to ischemic stroke. , 2013, Gene.
[61] A. von Eckardstein,et al. Plasma levels of trimethylamine-N-oxide are confounded by impaired kidney function and poor metabolic control. , 2015, Atherosclerosis.
[62] Mark D. Huffman,et al. Heart Disease and Stroke Statistics—2016 Update: A Report From the American Heart Association , 2016, Circulation.
[63] A. Mohammadi,et al. Expression levels of heat shock protein 60 and glucose-regulated protein 78 in response to trimethylamine-N-oxide treatment in murine macrophage J774A.1 cell line. , 2015, Cellular and molecular biology.
[64] Fredrik H. Karlsson,et al. Symptomatic atherosclerosis is associated with an altered gut metagenome , 2012, Nature Communications.
[65] C. Cho,et al. Trimethylamine-N-Oxide: Friend, Foe, or Simply Caught in the Cross-Fire? , 2017, Trends in Endocrinology & Metabolism.
[66] D. Gaudet,et al. In vivo variability of TMA oxidation is partially mediated by polymorphisms of the FMO3 gene. , 2001, Molecular genetics and metabolism.
[67] T. Karlsen,et al. The Carnitine-butyrobetaine-trimethylamine-N-oxide pathway and its association with cardiovascular mortality in patients with carotid atherosclerosis. , 2016, Atherosclerosis.
[68] S. Hazen,et al. Trimethylamine N‐Oxide and Mortality Risk in Patients With Peripheral Artery Disease , 2016, Journal of the American Heart Association.
[69] M. Weintraub,et al. The association of bile acid excretion and atherosclerotic coronary artery disease , 2011, Therapeutic advances in gastroenterology.
[70] E. Shephard,et al. Missense mutation in flavin-containing mono-oxygenase 3 gene, FMO3, underlies fish-odour syndrome , 1997, Nature Genetics.
[71] Brian J. Bennett,et al. Transmission of Atherosclerosis Susceptibility with Gut Microbial Transplantation* , 2014, The Journal of Biological Chemistry.
[72] Laxman Yetukuri,et al. The gut microbiota modulates host energy and lipid metabolism in mice[S] , 2010, Journal of Lipid Research.
[73] S. Kersten. Integrated physiology and systems biology of PPARα , 2014, Molecular metabolism.
[74] S. Hazen,et al. The contributory role of gut microbiota in cardiovascular disease. , 2014, The Journal of clinical investigation.
[75] N. Rotllan,et al. In vivo macrophage-specific RCT and antioxidant and antiinflammatory HDL activity measurements: New tools for predicting HDL atheroprotection. , 2009, Atherosclerosis.
[76] S. Hazen,et al. Non-lethal Inhibition of Gut Microbial Trimethylamine Production for the Treatment of Atherosclerosis , 2015, Cell.
[77] C. Palmeira,et al. Hepatic FXR: key regulator of whole-body energy metabolism , 2011, Trends in Endocrinology & Metabolism.
[78] Jens Nielsen,et al. Assessing the Human Gut Microbiota in Metabolic Diseases , 2013, Diabetes.
[79] S. Zeisel,et al. Trimethylamine N-Oxide, the Microbiome, and Heart and Kidney Disease. , 2017, Annual review of nutrition.
[80] R. Hegele,et al. Identification and Characterization of Trimethylamine-N-oxide Uptake and Efflux Transporters. , 2017, Molecular pharmaceutics.
[81] S. Hazen,et al. Measurement of trimethylamine-N-oxide by stable isotope dilution liquid chromatography tandem mass spectrometry. , 2014, Analytical biochemistry.
[82] S. Hazen,et al. Trimethylamine N‐Oxide Promotes Vascular Inflammation Through Signaling of Mitogen‐Activated Protein Kinase and Nuclear Factor‐κB , 2016, Journal of the American Heart Association.
[83] A. Magis,et al. A Multi-omic Association Study of Trimethylamine N-Oxide. , 2018, Cell reports.
[84] Richard G. Lee,et al. The TMAO-Generating Enzyme Flavin Monooxygenase 3 Is a Central Regulator of Cholesterol Balance. , 2015, Cell Reports.
[85] B. Kestenbaum,et al. Association of FMO3 Variants and Trimethylamine N-Oxide Concentration, Disease Progression, and Mortality in CKD Patients , 2016, PloS one.
[86] S. Hazen,et al. γ-Butyrobetaine is a proatherogenic intermediate in gut microbial metabolism of L-carnitine to TMAO. , 2014, Cell metabolism.
[87] Jian Yan,et al. Trimethylamine‐N‐oxide (TMAO) response to animal source foods varies among healthy young men and is influenced by their gut microbiota composition: A randomized controlled trial , 2017, Molecular nutrition & food research.
[88] M. Churnosov,et al. The Flavin-Containing Monooxygenase 3 Gene and Essential Hypertension: The Joint Effect of Polymorphism E158K and Cigarette Smoking on Disease Susceptibility , 2014, International journal of hypertension.
[89] M. Weintraub,et al. The Role of Bile Acid Excretion in Atherosclerotic Coronary Artery Disease , 2011, International journal of vascular medicine.
[90] R. Knight,et al. The Human Microbiome Project , 2007, Nature.
[91] Brian J. Bennett,et al. Trimethylamine-N-oxide, a metabolite associated with atherosclerosis, exhibits complex genetic and dietary regulation. , 2013, Cell metabolism.
[92] M. McCarthy,et al. Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice , 2006, Proceedings of the National Academy of Sciences.
[93] Brian J. Bennett,et al. Comparative Genome-Wide Association Studies in Mice and Humans for Trimethylamine N-Oxide, a Proatherogenic Metabolite of Choline and L-Carnitine , 2014, Arteriosclerosis, thrombosis, and vascular biology.
[94] S. Hazen,et al. Gut Microbial Metabolite TMAO Enhances Platelet Hyperreactivity and Thrombosis Risk , 2016, Cell.
[95] R. Obeid,et al. Plasma trimethylamine‐N‐oxide following supplementation with vitamin D or D plus B vitamins , 2017, Molecular nutrition & food research.